Loading institutional data...
Loading institutional data...
Held by 566 of 2,417 reporting institutions (99th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 20 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMB | $90.9B | 34.7× | 18.3× | 7.6× | 13.8% | — | 21.9% | 20.4% | 6.3% | 4.4× | 566 |
| KMI | $75.5B | 24.7× | 15.0× | 4.5× | 12.2% | — | 18.0% | 9.8% | 4.8% | 4.5× | 584 |
| ET | $72.0B | — | 9.8× | 0.8× | 3.5% | 25.8% | 5.2% | 9.0% | 3.8% | 4.7× | 461 |
| TRGP | $67.5B | 37.1× | 17.5× | 4.0× | 3.9% | 38.3% | 11.3% | 62.7% | 9.4% | 3.6× | 317 |
| LNG | $67.5B | 13.7× | 8.5× | 3.4× | 27.2% | — | 26.7% | 67.3% | 17.3% | 2.1× | 403 |
| OKE | $61.2B | 17.9× | 12.8× | 1.8× | 55.0% | 30.5% | 10.1% | 15.1% | 6.3% | 4.3× | 14 |
| VG | $37.0B | 17.2× | 11.3× | 2.7× | 177% | — | 19.8% | 40.5% | 6.7% | 5.2× | 70 |
| ATO | $29.1B | 23.1× | 16.5× | 6.2× | 12.9% | — | 25.5% | 8.8% | 5.3% | 3.8× | 298 |
| DTM | $12.7B | 28.9× | — | 10.2× | 26.7% | — | 35.5% | 9.3% | 5.5% | — | 171 |
| AM | $10.1B | 25.0× | 16.9× | 8.5× | 7.4% | — | 34.8% | 21.0% | 8.0% | 3.9× | 109 |
| NFG | $7.6B | 14.0× | 7.9× | 3.3× | 17.1% | 90.6% | 22.8% | 16.8% | 9.2% | 2.0× | 164 |
| AROC | $5.6B | 17.3× | — | 3.7× | 28.7% | 48.6% | 21.6% | 21.6% | 8.3% | — | 82 |
| NJR | $5.4B | 16.0× | 8.0× | 4.0× | 9.9% | — | 24.8% | 14.0% | 13.0% | 0.3× | 102 |
| SR | $5.2B | 20.1× | 12.0× | 2.1× | -4.5% | 58.8% | 11.0% | 8.0% | 3.4% | 5.7× | 83 |
| KGS | $4.7B | 52.6× | 11.8× | 3.6× | 12.8% | — | 6.2% | 6.7% | 2.1% | 4.1× | 69 |
| KNTK | $4.6B | 21.5× | 15.3× | 2.6× | 19.0% | — | 10.1% | -31.5% | 5.5% | 7.0× | 65 |
| CPK | $3.4B | 22.9× | 14.2× | 3.7× | 18.1% | — | 15.1% | 8.8% | 4.5% | 4.3× | 77 |
| CTRI | $2.2B | 86.0× | 13.6× | 0.7× | 13.1% | 8.3% | 0.8% | 2.6% | 1.4% | 3.0× | 23 |
| NWN | $2.1B | 18.0× | — | 1.6× | 11.8% | — | 8.8% | 7.7% | 2.9% | — | 64 |
| SMC | $427M | — | — | 0.8× | 30.8% | 73.5% | -1.1% | -1.1% | -0.4% | — | 4 |
| RGCO | $239M | 17.8× | 12.9× | 2.5× | 12.6% | — | 13.9% | 11.7% | 5.1% | 5.0× | 17 |
Peers = companies sharing WMB's sector (Natural Gas Transmission) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $74.35 today, the market must believe free cash flow compounds 14.9%/yr for a decade (off $2.28B on the 3-yr avg basis).
On the basis ($2.19B) the requirement is 15.4%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 14.9% is more optimistic than its 9-yr track record.
Default is 7.7% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 1.22B shares (market data) · net debt $28.66B
mean 446.8% · volatility σ 1401% · implied rate exceeded in 4/9 yrs
Central path = implied 14.9%/yr growth; shaded band = ±1σ (1401%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (243%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $2.44B dividends + $0 buybacks = $2.44B returned on $1.00B FCF.
8 consecutive years of dividend increases · 2%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 6%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
$1.34B of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~5.0% on $28.66B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.95B 100.0% | $10.50B 100.0% | $10.91B 100.0% | $10.96B 100.0% | $10.63B 100.0% | $7.72B 100.0% | $8.20B 100.0% | $8.69B 100.0% | $8.03B 100.0% | $7.50B 100.0% |
| Selling, General & Admin | $721.0M 6.0% | $708.0M 6.7% | $665.0M 6.1% | $636.0M 5.8% | $558.0M 5.3% | $466.0M 6.0% | $558.0M 6.8% | $569.0M 6.6% | $594.0M 7.4% | $722.0M 9.6% |
| Total Operating Expenses | $7.75B 64.9% | $7.16B 68.2% | $6.60B 60.5% | $7.95B 72.5% | $8.00B 75.2% | $5.52B 71.5% | $6.28B 76.6% | $7.92B 91.2% | $7.10B 88.5% | $6.81B 90.8% |
| Operating Income | $4.20B 35.1% | $3.34B 31.8% | $4.31B 39.5% | $3.02B 27.5% | $2.63B 24.8% | $2.20B 28.5% | $1.92B 23.4% | $768.0M 8.8% | $927.0M 11.5% | $689.0M 9.2% |
| Interest Expense | $1.44B 12.1% | $1.36B 13.0% | $1.24B 11.3% | $1.15B 10.5% | $1.18B 11.1% | $1.17B 15.2% | $1.19B 14.5% | $1.11B 12.8% | $1.08B 13.5% | $1.18B 15.7% |
| Interest & Investment Income | $40.0M 0.3% | $67.0M 0.6% | $79.0M 0.7% | $15.0M 0.1% | $7.0M 0.1% | — | — | — | — | — |
| Other Income (Expense), net | $69.0M 0.6% | $108.0M 1.0% | $99.0M 0.9% | $18.0M 0.2% | $6.0M 0.1% | -$43.0M -0.6% | $33.0M 0.4% | $92.0M 1.1% | -$25.0M -0.3% | $85.0M 1.1% |
| Pretax Income | $3.63B 30.3% | $2.99B 28.4% | $4.41B 40.4% | $2.54B 23.2% | $2.07B 19.5% | $277.0M 3.6% | $1.06B 13.0% | $331.0M 3.8% | $535.0M 6.7% | -$375.0M -5.0% |
| Income Tax Expense | $857.0M 7.2% | $640.0M 6.1% | $1.00B 9.2% | $425.0M 3.9% | $511.0M 4.8% | $79.0M 1.0% | $335.0M 4.1% | $138.0M 1.6% | -$1.97B -24.6% | -$25.0M -0.3% |
| Net Income | $2.62B 21.9% | $2.23B 21.2% | $3.18B 29.1% | $2.05B 18.7% | $1.52B 14.3% | $211.0M 2.7% | $850.0M 10.4% | -$155.0M -1.8% | $2.17B 27.1% | -$424.0M -5.7% |
| Per Share | ||||||||||
| EPS (Basic) | $2.14 | $1.82 | $2.61 | $1.68 | $1.25 | $0.17 | $0.70 | -$0.16 | $2.63 | -$0.57 |
| EPS (Diluted) | $2.14 | $1.82 | $2.60 | $1.67 | $1.24 | $0.17 | $0.70 | -$0.16 | $2.62 | -$0.57 |
| Weighted Avg Shares (Basic) | 1.22B | 1.22B | 1.22B | 1.22B | 1.22B | 1.21B | 1.21B | 973.6M | 826.2M | 750.7M |
| Weighted Avg Shares (Diluted) | 1.23B | 1.22B | 1.22B | 1.22B | 1.22B | 1.22B | 1.21B | 973.6M | 828.5M | 750.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 98th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 20% against ROIC 6% — 14% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| SG&A | 6.6 | 6.8 | 6.0 | 5.3 | 5.8 | 6.1 | 6.7 | 6.0 |
| Operating Income | 8.8 | 23.4 | 28.5 | 24.8 | 27.5 | 39.5 | 31.8 | 35.1 |
| Income Tax | 1.6 | 4.1 | 1.0 | 4.8 | 3.9 | 9.2 | 6.1 | 7.2 |
| Net Income | -1.8 | 10.4 | 2.7 | 14.3 | 18.7 | 29.1 | 21.2 | 21.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on WMB: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 9.83pts above its cost of capital, without much margin of safety.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 11.1% | 7.7% (today's — no rate published for this year) | 3.4pts |
| FY2020 | 14.3% | 7.7% (today's — no rate published for this year) | 6.6pts |
| FY2021 | 20.1% | 139.4% | -119.3pts |
| FY2022 | 20.0% | 129.3% | -109.2pts |
| FY2023 | 8.7% | 7.3% | 1.4pts |
| FY2024 | 6.6% | 8.4% | -1.7pts |
| FY2025 | 7.8% | 7.6% | 0.2pts |
| Now | 6.3% | 7.7% | -1.4pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | 9.2% | -5.7% |
| FY2017 | not reported | 11.5% | 27.1% |
| FY2018 | not reported | 8.8% | -1.8% |
| FY2019 | not reported | 23.4% | 10.4% |
| FY2020 | not reported | 28.5% | 2.7% |
| FY2021 | not reported | 24.8% | 14.3% |
| FY2022 | not reported | 27.5% | 18.7% |
| FY2023 | not reported | 39.5% | 29.1% |
| FY2024 | not reported | 31.8% | 21.2% |
| FY2025 | not reported | 35.1% | 21.9% |
Leverage and buybacks account for 14 points of the 20% return on equity in FY2025. The business earns 6% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$466M of goodwill — 3% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer.
The spread has been narrowing over the last three years.
Converts 1.12x of reported profit into free cash flow over 5 years, with accruals negative.
Conversion has deteriorated: 0.85x over three years against 1.12x over 5.
Covers interest 2.0x under stress — adequate, without much room.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 2.91x |
| 5% | 2.76x |
| 10% | 2.62x |
| 15% | 2.47x |
| 20% | 2.33x |
| 25% | 2.18x |
| 30% | 2.04x |
| 35% | 1.89x |
| 40% | 1.75x |
| 45% | 1.60x |
| 50% | 1.45x |
| 55% | 1.31x |
| 60% | 1.16x |
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025. No cash figure on the matching balance sheet, so no coverage line is drawn.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Net debt is 4.4x EBITDA, so coverage today depends on earnings holding up rather than on the balance sheet.
At $74.35, free cash flow must compound 14.92%/yr for 10 years. It has done -7.3%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | 42.5% | 14.9% |
| FY2021 | 19.9% | 14.9% |
| FY2022 | −2.6% | 14.9% |
| FY2023 | 29.8% | 14.9% |
| FY2024 | −29.8% | 14.9% |
| FY2025 | −58.1% | 14.9% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
The implied rate has been matched or beaten in 3 of the last 6 years.
| Step | Amount | Running total |
|---|---|---|
| Net income | $2.62B | $2.62B |
| Share-based comp | $93M | $2.71B |
| Other non-cash & working capital | $3.19B | $5.90B |
| Operating cash flow | $5.90B | $5.90B |
| Capex | −$4.89B | $1.00B |
| Free cash flow | $1.00B | $1.00B |
| FCF after SBC | $912M | $912M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -5.9% | not reported | not reported |
| FY2021 | 37.7% | not reported | not reported |
| FY2022 | 3.2% | not reported | not reported |
| FY2023 | -0.5% | not reported | not reported |
| FY2024 | -3.7% | not reported | not reported |
| FY2025 | 13.8% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -6.2 percent |
| FY2020 | -7.4 percent |
| FY2021 | -5.1 percent |
| FY2022 | -5.9 percent |
| FY2023 | -5.2 percent |
| FY2024 | -5.0 percent |
| FY2025 | -5.6 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Wilson Terrance Lane SVP & General Counsel | Open-market sale | 2,000 | $67.85 | $136k |
| 2026-09-01 | Wilson Terrance Lane SVP & General Counsel | Open-market sale | 2,000 | $75.56 | $151k |
| 2026-08-14 | 4 co-filers SVP & General Counsel | Open-market sale | 2,800 | $74.84 | $210k |
| 2026-08-14 | 4 co-filers SVP & General Counsel |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Open-market sale |
| 10,200 |
| $74.88 |
| $764k |
| 2026-08-14 | 4 co-filers SVP & General Counsel | Gift | 1,900 | $0.00 | $0 |
| 2026-08-14 | 4 co-filers SVP & General Counsel | Giftindirect | 100 | $0.00 | $0 |
| 2026-08-06 | Wingo Robert R. Executive Vice President | Tax withholding | 8,226 | $71.76 | $590k |
| 2026-08-05 | Turner Robb E Director | Grant | 2,785 | $71.81 | $200k |
| 2026-08-05 | Helms Lloyd W Jr Director | Grant | 2,785 | $71.81 | $200k |
| 2026-08-03 | Wilson Terrance Lane SVP & General Counsel | Open-market sale | 2,000 | $70.65 | $141k |
| 2026-07-01 | Wilson Terrance Lane SVP & General Counsel | Open-market sale | 2,000 | $74.16 | $148k |
| 2026-06-25 | 3 co-filers EVP & CFO | Option exercise | 1,899 | $24.98 | $47k |
| 2026-06-25 | 3 co-filers EVP & CFO | Tax withholding | 1,176 | $77.62 | $91k |
| 2026-06-25 | 3 co-filers EVP & CFO | Option exercise | 1,899 | $24.98 | — |
| 2026-06-01 | Wilson Terrance Lane SVP & General Counsel | 10b5-1 plan sale | 2,000 | $71.30 | $143k |
| 2026-05-19 | Bergstrom Stephen W Director | Gift | 16,400 | $0.00 | $0 |
| 2026-05-15 | 6 co-filers Senior Vice President | Option exercise | 836 | $28.15 | $24k |
| 2026-05-15 | 6 co-filers Senior Vice President | Exercise & sell | 836 | $78.13 | $65k |
| 2026-05-15 | 6 co-filers Senior Vice President | Option exercise | 1,664 | $29.09 | $48k |
| 2026-05-15 | 6 co-filers Senior Vice President | Exercise & sell | 1,664 | $78.17 | $130k |
| 2026-05-15 | 6 co-filers Senior Vice President | Option exercise | 836 | $28.15 | — |
| 2026-05-15 | 6 co-filers Senior Vice President | Option exercise | 1,664 | $29.09 | — |
| 2026-05-14 | Larsen Larry C Executive Vice President & COO | Open-market sale | 12,000 | $76.48 | $918k |
| 2026-05-06 | Porter John Dean EVP & CFO | Open-market sale | 50,000 | $75.37 | $3.8m |
| 2026-05-01 | Wilson Terrance Lane SVP & General Counsel | Open-market sale | 2,000 | $76.35 | $153k |
| 2026-04-28 | Lockhart Carri A. Director | Grant | 3,250 | $73.04 | $237k |
| 2026-04-28 | Tyson Jesse J Director | Grant | 3,415 | $73.04 | $249k |
| 2026-04-28 | Muncrief Richard E Director | Grant | 3,415 | $73.04 | $249k |
| 2026-04-28 | Ragauss Peter A Director | Grant | 4,873 | $73.04 | $356k |
| 2026-04-28 | Robeson Rose M Director | Grant | 3,818 | $73.04 | $279k |
| 2026-04-28 | Creel Michael A Director | Grant | 4,873 | $73.04 | $356k |
| 2026-04-28 | Spence William H Director | Grant | 5,086 | $73.04 | $371k |
| 2026-04-28 | Sheffield Scott D Director | Grant | 4,873 | $73.04 | $356k |
| 2026-04-28 | Bergstrom Stephen W Director | Grant | 10,355 | $73.04 | $756k |
| 2026-04-01 | Wilson Terrance Lane SVP & General Counsel | 10b5-1 plan sale | 2,000 | $71.75 | $144k |
| 2026-03-13 | Fazel Payvand Senior Vice President | Open-market sale | 2,898 | $73.15 | $212k |
| 2026-03-11 | Rinke Todd J. Senior Vice President | Open-market sale | 7,364 | $74.39 | $548k |
| 2026-03-09 | 2 co-filers Senior Vice President | Grant | 5,637 | $73.18 | $413k |
| 2026-03-09 | 3 co-filers Senior Vice President | Tax withholding | 1,464 | $73.18 | $107k |
| 2026-03-09 | 3 co-filers Senior Vice President | Grant | 5,637 | $73.18 | $413k |